Ontruzant

E2042591 UNEXPLORED

Ontruzant is a biosimilar version of trastuzumab used in the treatment of HER2-positive breast and gastric cancers.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
Ontruzant canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Samsung Bioepis → hasProduct → Ontruzant ⓘ